Burbank Jeffrey H 4
4 · NxStage Medical, Inc. · Filed Mar 16, 2018
Insider Transaction Report
Form 4
Burbank Jeffrey H
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2018-03-14$18.59/sh+36,273$674,315→ 809,685 total - Tax Payment
Common Stock
2018-03-14$24.05/sh−28,039$674,338→ 781,646 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-14−36,273→ 0 totalExercise: $18.59From: 2011-06-27Exp: 2018-05-26→ Common Stock (36,273 underlying)